Three-dimensional isobolographic analysis of interactions between lamotrigine and clonazepam in maximal electroshock-induced seizures in mice

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 370, Issue 5, 2004, Pages 369-380

  Luszczki, Jarogniew J ^a   Czuczwar, Stanislaw J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Clonazepam; Drug interactions; Lamotrigine; Three dimensional isobolographic analysis

Indexed keywords

CLONAZEPAM; LAMOTRIGINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE CONTROL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; ELECTRIC SHOCK; ISOBOLOGRAPHY; MALE; MOUSE; NONHUMAN; SEIZURE; TECHNIQUE; THREE DIMENSIONAL IMAGING;

ANIMALS; BRAIN; CLONAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROSHOCK; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MICE; TRIAZINES;

EID: 11144260920     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-0983-9     Document Type: Article

References (43)

1. Berenbaum MC (1989) What is synergy? Pharmacol Rev 41:93-141 [Erratum in Pharmacol Rev 41:422 (1990)]
2. Besag FM, Berry DJ, Pool F, Newbery JE, Subel B (1998) Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction? Epilepsia 39:183-187
3. Borowicz KK, Swiader M, Luszczki J, Czuczwar SJ (2002) Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice - an isobolographic analysis. Epilepsia 43:956-963
4. Cadart M, Marchand S, Pariat C, Bouquet S, Couet W (2002) Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats. Pharm Res 19:209-214
5. Calabresi P, Centonze D, Marfia GA, Pisani A, Bernardi G (1999) An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons. Br J Pharmacol 126:689-696
6. Cheung H, Kamp D, Harris E (1992) An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13:107-112
7. Deckers CL, Czuczwar SJ, Hekster YA, Keyser A, Kubova H, Meinardi H, Patsalos PN, Renier WO, Van Rijn CM (2000) Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 41:1364-1374
8. Fischer RS (1989) Animal models of the epilepsies. Brain Res Rev 14:245-278
9. Gasior M, Ungard JT, Witkin JM (1999) Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J Pharmacol Exp Ther 290:1148-1156
10. Gebhart GF (1992) Topical reviews: a new type of report in pain. Pain 49:1
11. Gessner PK (1995) Isobolographic analysis of interactions: an update on applications and utility. Toxicology 105:161-179
12. Glantz SA, Slinker BK (2001) Primer of applied regression and analysis of variance, 2nd edn. MacGraw-Hill, New York
13. Greco WR, Bravo G, Parsons JC (1995) The search for synergy: a critical review from response surface perspective. Pharmacol Rev 47:331-385
14. Haefely W (1989) Benzodiazepines. Mechanisms of action. In: Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE (eds) Antiepileptic drugs, 3rd edn. Raven, New York, pp 721-734
15. Jozwiak S, Terczynski A (2000) Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy. Seizure 9:486-492
16. Kanzawa F, Nishio K, Fukuoka K, Fukuda M, Kunimoto T, Saijo N (1997) Evaluation of synergism by a novel three-dimensional model for the combined action of cisplatin and etoposide on the growth of a human small-cell lung-cancer cell line, SBC-3. Int J Cancer 71:311-319
17. Leach MJ, Baxter MG, Critchley MA (1991) Neurochemical and behavioral aspects of lamotrigine. Epilepsia 32 (Suppl 2):S4-S8
18. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113
19. Loewe S (1953) The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3:285-290
20. Löscher W, Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2:145-181
21. Löscher W, Fassbender CP, Nolting B (1991) The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 8:79-94
22. Luszczki JJ, Czuczwar SJ (2003) Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics-a comparative study. Epilepsy Res 56:27-42
23. Luszczki JJ, Czuczwar SJ (2004) Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study. Naunyn-Schmiedeberg's Arch Pharmacol 369:434-446
24. Luszczki JJ, Czuczwar M, Kis J, Krysa J, Pasztelan I, Swiader M, Czuczwar SJ (2003a) Interactions of lamotrigine with topiramate and first-generation antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia 44:1003-1013
25. Luszczki JJ, Borowicz KK, Swiader M, Czuczwar SJ (2003b) Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia 44:489-499
26. Luszczki JJ, Swiader M, Czuczwar M, Kis J, Czuczwar SJ (2003c) Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. Pharmacol Biochem Behav 75:319-327
27. Macdonald RL (2002) Benzodiazepine. Mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, Perucca E (eds) Antiepileptic drugs, 5th edn. Lippincott, Philadelphia, pp 179-186
28. McLean MJ, Macdonald RL (1988) Benzodiazepines, but not beta carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture. J Pharmacol Exp Ther 244:789-795
29. Pöch G (1993) Combined effects of drugs and toxic agents. Modern evaluation in theory and practice. Springer, Wien
30. Porreca F, Jiang Q, Tallarida RJ (1990) Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction. Eur J Pharmacol 179:463-468
31. Prichard MN, Prichard LE, Baguley WA, Nassiri MR, Shipman C (1991) Three-dimensional analysis of the synergistic cytotoxicity of gancyclovir and zidovudine. Antimicrob Agents Chemother 35:1060-1065
32. Prichard MN, Prichard LE, Shipman C (1993) Strategic design and tree-dimensional analysis of antiviral drug combinations. Antimicrob Agents Chemother 37:540-545
33. Stephen LJ, Brodie MJ (2002) Seizure freedom with more than one antiepileptic drug. Seizure 11:349-351
34. Sühnel J (1992) Zero interaction response surfaces, interaction functions and difference response surfaces for combinations of biologically active agents. Arzneimittelforschung 42:1251-1258
35. Sühnel J (1998) Parallel dose-response curves in combination experiments. Bull Math Biol 60:197-213
36. Tallarida RJ (1992) Statistical analysis of drug combinations for synergism. Pain 49:93-97
37. Tallarida RJ (2000) Drug synergism and dose-effect data analysis. Chapman & Hall/CRC, Boca Raton
38. Tallarida RJ (2001) Drug synergism: its detection and applications. J Pharmcol Exp Ther 298:865-872
39. Tallarida RJ (2002) The interaction index: a measure of drug synergism. Pain 98:163-168
40. Tallarida RJ, Stone DJ, McCary JD, Raffa RB (1999) Response surface analysis of synergism between morphine and clonidine. J Pharmcol Exp Ther 289:8-13
41. Wang SJ, Huang CC, Hsu KS, Tsai JJ, Gean PW (1996) Inhibition of N-type calcium currents by lamotrigine in rat amygdala neurones. Neuroreport 7:3037-3040
42. ++ influx in dissociated amygdala neurons. Synapse 29:355-362
43. White HS, Woodhead JH, Wilcox KS, Stables JP, Kupferberg HJ, Wolf HH (2002) Discovery and preclinical development of antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS, Perucca E (eds) Antiepileptic drugs, 5th edn. Lippincott, Philadelphia, pp 36-48